Experimentally, FLT3 inhibition led to apoptosis in FLT3 positive AML cells79, and dasatinib was shown to reverse induced resistance to FLT3-inhibition in the treatment of AML80. This evidence concerns the gene FLT3 and acute myeloid leukemia.